·Paper Publications
MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
Release time:2020-08-21  Hits:
Journal: Cardiovascular Diabetology. 2018;17(1):123.
Journal: Cardiovascular Diabetology. 2018;17(1):123.